Character Biosciences
Character Biosciences is a precision medicine company focused on developing targeted therapies for progressive polygenic diseases, starting with ophthalmology. The company utilizes an AI-driven, genomics-based platform to identify disease drivers and develop therapeutics that improve clinical outcomes, specifically for degenerative eye diseases like age-related macular degeneration (AMD). They are aiming to bring new therapies to patients by advancing lead programs into clinical trials.
Funding Round: Series B
Funding Amount: $93M
Date: 25-Mar-2025
Investors: aMoon, Luma Group, Bausch + Lomb, Jefferson Life Sciences, Innovation Endeavors, Catalio Capital Management, S32, KdT Ventures
Markets: Biotech, Healthcare, Ophthalmology
HQ: Jersey City, New Jersey, United States
Founded: 2018
Website: https://www.characterbio.com/
LinkedIn: https://www.linkedin.com/company/character-biosciences
Crunchbase: https://www.crunchbase.com/organization/clover-therapeutics
Leave a Comment
Comments
No comments yet.